A phase 2 study of oxaliplatin (o) – Capecitabine (X) chemiotherapy in metastatic breast cancer (MBC) patients pretreated whit anthracyclines an taxanes.

Research output: Contribution to conferenceOther

Original languageUndefined/Unknown
Pages128-131
Publication statusPublished - 2004

Cite this